MetaVia Inc.

NASDAQ: MTVA
Share price (3/28/25): $1.57
Market cap (3/28/25): $13.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Updated info for already-effective prospectus

Prospectus supplement

Initial registration of new securities

Exempt offering of securities

Ownership Filter

Woodworth Marshall H

Armistice Capital, LLC

Armistice Capital, LLC

News Filter

Top-Line Data From MAD Part 2 of the Phase 1 Trial of DA-1726 Expected in April of 2025

Investor Presentation

Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients With Presumed MASH

Investor Presentation

NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones With Name Change to MetaVia - Reflecting the Company’s Focus on Cardiometabolic Diseases

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness